Protein product based on truncated neurotrophic factor, polynucleotide encoding this protein product, vector comprising such polynucleotide, prokaryotic or eukaryotic host cell transformed or transfected with such polynucleotide, process for obtaining said protein product, pharmaceutical composition comprising the protein product, process for preparing this composition and use said product
Disclosed are proteins, referred to as truncated glial cell line-derived neurotrophic factor (truncated GDNF proteins), that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells, and processes for obtaining the truncated GDNF proteins by recombinant genetic engineering techniques.Disclosed are proteins, referred to as truncated glial cell line-derived neurotrophic factor (truncated GDNF proteins), that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells, and processes for obtaining the truncated GDNF proteins by recombinant genetic engineering techniques.
